DOYLESTOWN, Pa., Jan. 26, 2017 -- Crawford Healthcare, Inc. (“Crawford” or the “Company”) announced today the signing of a national group purchasing agreement with Premier Inc. (“Premier”), a leading healthcare improvement company. This three-year award includes both the Primary/Secondary wound care dressings and wound debridement category and the skin cleansers, barrier and lotion products category. Effective April 1st, these two categories will allow Crawford’s full portfolio of products to be offered at specially negotiated pricing and terms to members of Premier’s alliance, which includes 3,750 hospitals and 130,000 other providers. Premier operates one of the largest healthcare group purchasing organizations (GPOs) in the United States.
Crawford’s innovative line of advanced wound and skin care products was designed with novel technologies to advance the standard of care in the exudate management, infection control and skin protection segments. This national agreement combines Crawford’s products with Premier’s integrated data and analytics, collaboratives, supply chain solutions, advisory and other services to enable better care and outcomes at a lower cost.
“This new contract award is a testament to the clinical acceptance of Crawford’s portfolio and our growth within Premier alliance hospitals over the past year. We look forward to the opportunity to partner with more Premier members who share our values and are striving to overcome the clinical and economic challenges that everyone is facing,” says Terry Bromley, Senior Vice President and General Manager of Crawford’s U.S. operations.
For more information about Crawford Healthcare, Inc. or its products, please visit http://crawfordhealthcare.us/
About Crawford Healthcare, Inc.
Crawford Healthcare, Inc., is a rapidly growing international company dedicated to developing innovative treatments and effective dermatological, wound care, and diagnostic products for the care and repair of skin. The Company has worked closely with healthcare professionals for more than 15 years from the international head office of its parent company, Crawford Healthcare Holdings Limited (the “Crawford Group”), in Knutsford, Cheshire, U.K. In early 2013, the Crawford Group expanded its operations and opened a United States office in Doylestown, Pa., that focuses on the Company’s portfolio of advanced wound care products. To help lead its U.S. business, the Crawford Group has assembled a skilled management team with long-standing industry backgrounds in the advanced wound care arena. The team offers more than 150 years of collective experience in the field and has deployed a nationwide direct sales team dedicated to wound, skin, and burn care.
Contact: Terry Bromley Senior Vice President & General Manager Crawford Healthcare, Inc. 267.532.1284 [email protected]


American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Indian Refiners Scale Back Russian Oil Imports as U.S.-India Trade Deal Advances
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
Washington Post Publisher Will Lewis Steps Down After Layoffs
Anta Sports Expands Global Footprint With Strategic Puma Stake
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
Innovent Biologics Shares Rally on New Eli Lilly Oncology and Immunology Deal
Kroger Set to Name Former Walmart Executive Greg Foran as Next CEO
SpaceX Pivots Toward Moon City as Musk Reframes Long-Term Space Vision
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate 



